Publication | Closed Access

Plasma Triglycerides and Cardiovascular Events in the Treating to New Targets and Incremental Decrease in End-Points Through Aggressive Lipid Lowering Trials of Statins in Patients With Coronary Artery Disease

Metabolic SyndromeNew TargetsCardiovascular DiseaseHealth PolicyMedicineDiabetesHyperlipidemiaPlasma TriglyceridesPublic HealthPharmacologyAtherosclerosisDyslipidemiaCardiovascular EventsCoronary Artery Disease